Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: Celecoxib may possess disease-modifying properties

Osteoarthritis and Cartilage

Volumn 22, Issue 10, 2014, Pages 1639-1650

  Panahifar, A ^a   Jaremko, J L ^a   Tessier, A G ^a   Lambert, R G ^a   Maksymowych, W P ^a   Fallone, B G ^a   Doschak, M R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Celecoxib; CT; Glucosamine; MRI; Osteoarthritis; Osteophytes

Indexed keywords

CELECOXIB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOSAMINE; PLACEBO; CYCLOOXYGENASE 2 INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CYST; BONE MARROW DISEASE; BONE MARROW EDEMA; BONE MARROW LESION; CARTILAGE DEGENERATION; CHONDROPATHY; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMUR CYST; FOLLOW UP; HISTOPATHOLOGY; JOINT EFFUSION; KNEE ARTHRITIS; MICRO-COMPUTED TOMOGRAPHY; MYELOFIBROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OSTEOARTHRITIS; OSTEOPHYTE; OUTCOME ASSESSMENT; PRE-CLINICAL IMAGING DEVICE; RAT; RAT ARTHRITIS KNEE SCORING SYSTEM; RELIABILITY; SCLEROSIS; SCORING SYSTEM; SUBCHONDRAL SCLEROSIS; SYNOVITIS; TIBIA CYST; ANIMAL; ANTERIOR CRUCIATE LIGAMENT; ARTICULAR CARTILAGE; BONE CYSTS; BONE MARROW DISEASES; DISEASE MODEL; KNEE INJURY; OSTEOARTHRITIS, KNEE; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SURGERY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; BONE CYSTS; BONE MARROW DISEASES; CARTILAGE, ARTICULAR; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLUCOSAMINE; KNEE INJURIES; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS, KNEE; OSTEOPHYTE; PYRAZOLES; RATS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; SYNOVITIS; X-RAY MICROTOMOGRAPHY;

EID: 84908207627     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.06.013     Document Type: Article

References (31)

1. McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000, 283(11):1469-1475.
2. Sawitzke A.D., Shi H., Finco M.F., Dunlop D.D., Bingham C.O., Harris C.L., et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008, 58(10):3183-3191.
3. Aghazadeh-Habashi A., Jamali F. The glucosamine controversy; a pharmacokinetic issue. JPharm Pharm Sci 2011, 14(2):264-273.
4. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16(4):494-502.
5. Peterfy C.G., Guermazi A., Zaim S., Tirman P.F., Miaux Y., White D., et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004, 12(3):177-190.
6. Hunter D.J., Lo G.H., Gale D., Grainger A.J., Guermazi A., Conaghan P.G. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008, 67(2):206-211.
7. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004, 50(4):1193-1206.
8. Jaremko J.L., Lambert R.G., Zubler V., Weber U., Loeuille D., Roemer F.W., et al. Methodologies for semiquantitative evaluation of hip osteoarthritis by magnetic resonance imaging: approaches based on the whole organ and focused on active lesions. JRheumatol 2014, 41(2):359-369.
9. Mankin H.J., Dorfman H., Lippiello L., Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. JBone Jt Surg Am 1971, 53(3):523-537.
10. van der Sluijs J.A., Geesink R.G., van der Linden A.J., Bulstra S.K., Kuyer R., Drukker J. The reliability of the Mankin score for osteoarthritis. JOrthop Res 1992, 10(1):58-61.
11. Panahifar A., Maksymowych W.P., Doschak M.R. Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation. Osteoarthritis Cartilage 2012, 20(7):694-702.
12. Fukai A., Kamekura S., Chikazu D., Nakagawa T., Hirata M., Saito T., et al. Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice. Arthritis Rheum 2012, 64(1):198-203.
13. van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994, 71(2):279-290.
14. Liu H., Peng Y., Liu F., Li J., Chen X., Liu Y., et al. Aselective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells. Cell Biol Int 2007, 31(5):508-515.
15. Massicotte F., Fernandes J.C., Martel-Pelletier J., Pelletier J.P., Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 2006, 38(3):333-341.
16. Okazaki K., Jingushi S., Ikenoue T., Urabe K., Sakai H., Ohtsuru A., et al. Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. Endocrinology 1999, 140(10):4821-4830.
17. Akatsu T., Takahashi N., Debari K., Morita I., Murota S., Nagata N., et al. Prostaglandins promote osteoclast like cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures. JBone Min Res 1989, 4(1):29-35.
18. McErlain D.D., Ulici V., Darling M., Gati J.S., Pitelka V., Beier F., et al. An invivo investigation of the initiation and progression of subchondral cysts in a rodent model of secondary osteoarthritis. Arthritis Res Ther 2012, 14(1):R26.
19. Zanetti M., Bruder E., Romero J., Hodler J. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 2000, 215(3):835-840.
20. Taljanovic M.S., Graham A.R., Benjamin J.B., Gmitro A.F., Krupinski E.A., Schwartz S.A., et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol 2008, 37(5):423-431.
21. Xu L., Hayashi D., Roemer F.W., Felson D.T., Guermazi A. Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis. Semin Arthritis Rheum 2012, 42(2):105-118.
22. Crema M.D., Roemer F.W., Zhu Y., Marra M.D., Niu J., Zhang Y., et al. Subchondral cystlike lesions develop longitudinally in areas of bone marrow edema-like lesions in patients with or at risk for knee osteoarthritis: detection with MR imaging-the MOST study. Radiology 2010, 256(3):855-862.
23. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006, 14(10):1033-1040.
24. Libicher M., Ivancic M., Hoffmann M., Wenz W. Early changes in experimental osteoarthritis using the pond-nuki dog model: technical procedure and initial results of invivo MR imaging. Eur Radiol 2005, 15(2):390-394.
25. Wang Y.X. Invivo magnetic resonance imaging of animal models of knee osteoarthritis. Lab Anim 2008, 42(3):246-264.
26. Abduljalil A.M., Robitaille P.M. Macroscopic susceptibility in ultra high field MRI. JComput Assist Tomogr 1999, 23(6):832-841.
27. Appel H., Loddenkemper C., Grozdanovic Z., Ebhardt H., Dreimann M., Hempfing A., et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006, 8(5):R143.
28. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum 1986, 29(8):1039-1049.
29. Kerkhof HJ, Bierma-Zeinstra SM, Arden NK, Metrustry S, Castano-Betancourt M, Hart DJ, etal. Prediction model for knee osteoarthritis incidence, including clinical, genetic and biochemical risk factors. Ann Rheum Dis Published Online First: [2013 Aug 20]. http://dx.doi.org/10.1136/annrheumdis-2013-203620.
30. Oehler S., Neureiter D., Meyer-Scholten C., Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002, 20(5):633-640.
31. Sokolove J., Lepus C.M. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 2013, 5(2):77-94.